Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM2VIDK)

Drug Name

Triphenylacetic acid methyl ester Drug Info

Synonyms

methyl triphenylacetate; methyl 2,2,2-triphenylacetate; 5467-21-0; triphenylacetic acid methyl ester; CHEMBL270495; 2-TRIPHENYL METHYL ACETIC ACID; NSC28082; methyl triphenyl-acetate; AC1Q5YRI; SCHEMBL7258414; AC1L5M42; CTK5A2196; DTXSID30282812; ZPGOQUZHRVSLML-UHFFFAOYSA-N; ZINC4696706; BDBM50371380; NSC-28082; Benzeneacetic acid, a,a-diphenyl-, methyl ester; benzeneacetic acid, .alpha.,.alpha.-diphenyl-, methyl ester

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 231627
CAS Number: CAS 5467-21-0
TTD Drug ID: DM2VIDK

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Calcium-activated potassium channel (KCN)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Chlorzoxazone	DMCYVDT	Acute pain	MG31	Approved	[2]
Charybdotoxin	DMKN345	Scorpion envenoming syndrome	8D43	Approved	[3]
ICA-17043	DMRFY7I	Alzheimer disease	8A20	Phase 2	[1]
4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one	DMKMH5L	Discovery agent	N.A.	Investigative	[4]
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole	DMQEJVU	Conjunctival fibrosis	9A61.3	Investigative	[4]
4-fluorophenyl-2,2-diphenylacetamide	DMI03KV	Discovery agent	N.A.	Investigative	[1]
N-methyl-2,2,2-triphenylacetamide	DMQGRMO	Discovery agent	N.A.	Investigative	[1]
TRIPHENYLMETHANAMINE	DM3CQIZ	Discovery agent	N.A.	Investigative	[1]
N,N-dimethyl-2,2,2-triphenylacetamide	DM9XZJN	Discovery agent	N.A.	Investigative	[1]
(2-fluorophenyl)-(4-fluorophenyl)phenylacetamide	DMFV76H	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Calcium-activated potassium channel (KCN)	TTMNI76	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82.
2	Chlorzoxazone inhibits contraction of rat thoracic aorta. Eur J Pharmacol. 2006 Sep 18;545(2-3):161-6.
3	Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood. 2006 Oct 1;108(7):2223-8.
4	Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2299-304.